Sept. 9, 2026 — The 2026 American Society for Radiation Oncology (ASTRO) Annual Meeting, will take place Sept. 26 to 30, in Boston, Massachusetts.
The meeting will feature more than 2,500 abstract presentations, expert panels on topics such as artificial intelligence and radiopharmaceutical therapy, and keynote addresses from physician leaders Scott Gottlieb, MD, former Commissioner of the U.S. Food and Drug Administration, and Ezekiel Emanuel, MD, PhD, award-winning oncologist and bioethicist.
ASTRO’s 2026 Annual Meeting also will feature late-breaking and phase III trials alongside research spanning cancer care and emerging applications of radiation medicine. Press program studies will spotlight major randomized comparisons of radiation approaches for brain metastases, pancreas cancer and prostate cancer; studies exploring how radiation may be used beyond cancer, including low-dose treatment for knee osteoarthritis and radiosurgical capsulotomy for treatment-resistant major depression; and other practice-changing research.
Led by ASTRO President Neha Vapiwala, MD, FASTRO, the meeting is expected to attract more than 10,000 oncologists, clinicians, researchers and other health care professionals from around the globe. The meeting theme, “Data to Dialogue: Communicating Radiotherapy's Value to Advance Care,” focuses on fostering meaningful conversations with patients and other key stakeholders about the far-reaching uses and benefits of radiation therapy.
September 29, 2026 
